1. Home
  2. TH vs MLTX Comparison

TH vs MLTX Comparison

Compare TH & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$14.21

Market Cap

1.4B

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$16.09

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
MLTX
Founded
1978
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
TH
MLTX
Price
$14.21
$16.09
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
$16.50
$27.50
AVG Volume (30 Days)
1.7M
1.2M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,635,000.00
N/A
Revenue This Year
$17.45
N/A
Revenue Next Year
$38.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$5.95
52 Week High
$16.12
$62.75

Technical Indicators

Market Signals
Indicator
TH
MLTX
Relative Strength Index (RSI) 60.73 40.48
Support Level $7.95 $15.90
Resistance Level $15.10 $16.69
Average True Range (ATR) 0.56 0.87
MACD -0.27 -0.22
Stochastic Oscillator 20.04 2.42

Price Performance

Historical Comparison
TH
MLTX

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: